Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus
Authors:
Open Access
- 15 January 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (2) , 147-153
Abstract
Prevention of bacterial infection, which is a leading cause of morbidity in patients with rheumatoid arthritis (RA) and systemic lupus erythematosusKeywords
This publication has 20 references indexed in Scilit:
- Immunopathogenesis and spectrum of infections in systemiclupus erythematosusSeminars in Arthritis and Rheumatism, 1996
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- The Clinical Effectiveness of Pneumococcal Vaccine in the ElderlyAnnals of Internal Medicine, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Pneumococcal Vaccine: Clinical Efficacy and EffectivenessAnnals of Internal Medicine, 1982
- Impaired response to pneumococcal vaccine in systemic lupus erythematosusArthritis & Rheumatism, 1980
- A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosusArthritis & Rheumatism, 1979
- Duration and death in systemic lupus erythematosus. An analysis of 249 cases1974
- Disseminated Lupus Erythematosus Occurring among Student Nurses*New England Journal of Medicine, 1948